Company Filing History:
Years Active: 2011
Title: Michael Koldobskiy: Innovator in Anti-Cancer Drug Development
Introduction
Michael Koldobskiy is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of cancer research through his innovative work on anti-cancer drugs. His research focuses on the regulation of cell survival, which is crucial in the development of effective cancer treatments.
Latest Patents
Koldobskiy holds a patent titled "Regulation of cell survival by HSP90 and IP6K2." This patent identifies anti-cancer drugs by screening for agents and compounds that inhibit the binding of HSP90 and IP6K2. The patent outlines methods for utilizing in vitro and in vivo assays to monitor various phenomena associated with the binding or inhibition, including cell death, subcellular localization, catalytic activity of IP6K2, and IP7 formation.
Career Highlights
Michael Koldobskiy is affiliated with The Johns Hopkins University, where he conducts his research. His work has garnered attention for its potential impact on cancer treatment and drug development. Koldobskiy's innovative approach to understanding cell survival mechanisms positions him as a key figure in the ongoing fight against cancer.
Collaborations
Koldobskiy has collaborated with esteemed colleagues such as Solomon H. Snyder and Anutosh Chakraborty. These collaborations have further enhanced the depth and breadth of his research, contributing to advancements in the field.
Conclusion
Michael Koldobskiy is a pioneering inventor whose work in anti-cancer drug development is making a significant impact in the medical field. His innovative research continues to pave the way for new treatment options for cancer patients.